Compounds > ytterbium
Page last updated: 2024-08-22

ytterbium and Cancer of Ovary

ytterbium has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheung, L; Gano, J; Kavanagh, JJ; Kudelka, AP; Murray, JL; Rosenblum, MG; Verschraegen, CF1

Trials

1 trial(s) available for ytterbium and Cancer of Ovary

ArticleYear
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:5

    Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Antibodies, Neoplasm; Antigens, Neoplasm; Ascites; Ascitic Fluid; Bone and Bones; Bone Marrow; Bone Marrow Diseases; Carcinoma; Chelating Agents; Chelation Therapy; Dose-Response Relationship, Immunologic; Dose-Response Relationship, Radiation; Edetic Acid; Fallopian Tube Neoplasms; Female; Glycoproteins; Half-Life; Humans; Injections, Intraperitoneal; Mice; Middle Aged; Neoplasm, Residual; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Injuries; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Tissue Distribution; Treatment Outcome; Ytterbium

1999